InvestorBrandNetwork (IBN) Content Platform

Save Foods (NASDAQ: SVFD), an agrifood tech company specializing in eco crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides, is officially kicking off the northern hemisphere citrus season. The company announced that it expects 400,000 tons of citrus fruit will be treated at new and existing packing houses in Turkey, Egypt, Mexico, the United States and Israel during the season, which begins in November and runs through April 2023. According to the announcement, the company anticipates adding new packing houses to its customer base during the coming months. “Following our marketing efforts and successful pilots, our commercial operations are expanding, and we are expecting to add five new customers this citrus season,” said Save Foods CEO Dan Sztybel in the press release. “It’s imperative for our clients to export superior products to ensure streamlined supply chain efficiencies, and our safe and efficient solutions are proving to be the preferred choice across our new and recurrent customers like SiCar Farms, Sun Pacific and Mehadrin. We look forward to working with a larger client base this citrus season in the northern hemisphere, which is projected to be bigger than last year, and adding new customers in the southern hemisphere later in 2023, which will allow us to treat citrus fruit all year round for the first time. We are also preparing to implement our treatments commercially in avocado, mango, bell peppers, and berries in both hemispheres.”

To view the full press release, visit https://ibn.fm/HdRpP

About Save Foods Inc.

Save Foods is an innovative, dynamic company addressing two of the most significant challenges in the agrifood tech industry: food waste and loss and food safety. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and consumers alike. SVFD’s initial applications are in post-harvest treatments in fruit and vegetable packing houses that process produce such as citrus, avocado, pears, apples and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of hazardous chemicals and their residues, Save Foods treatments not only prolong fresh produce shelf life and reduce food loss and waste, but they also ensure a safe, natural, and healthy product. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Sigma Additive Solutions (NASDAQ: SASI), a leading developer of quality-assurance software to the commercial 3D printing industry, is partnering with Dyndrite(TM) to build connected in-process data software using Dyndrite’s application development kit. Dyndrite provides the GPU-accelerated computation engine that is used to create next-generation digital manufacturing hardware and software. According to the announcement, the agreement expands the development of SASI’s PrintRite3D(R) by connecting the proprietary platform’s visualization and analysis on Dyndrite’s Additive Developer Kit (“ADK”), accelerating additive manufacturing development and increasing production quality. The combination will provide a single-user experience for CAM, materials and process development and toolpath creation, as well as in-process quality data and analytics. “It’s been long requested by users to have a single environment for the design-to-part qualification stack,” said Sigma Additive Solutions GM of EMEA Stephan Kuehr in the press release. “This agreement is a key step in empowering the user to marry their in-process quality data to the directly generated toolpaths sent to the machine. This union will enable the user to make quality and toolpath decisions faster, take control of their data, and make it actionable.”

In addition, Sigma also released is financial and operational report for the third quarter 2022, the period ended Sept. 30, 2022. Highlights of the report include the expansion of SASI’s OEM footprint with in-process quality assurance software being certified as PrintRite3D Ready to work with SLM Solutions’ industrial metal additive manufacturing machines; a partnership with Novanta, a premier global supplier of laser photonics, to offer the first fully integrated scan head with quality assurance; and the beta launch of PrintRite3D Machine Health, a software focused on standardizing machine health data logs, which will ultimately connect to the company’s future broader software product base. Revenue for Q3 2022 totaled $188,245, compared to $700,237 for the same period in 2021; gross profit for the quarter came in at $108,532, resulting in a gross margin of 58%, and operating expenses were $2.4 million. “As noted last quarter, we are tracking the following key performance indicators (‘KPIs’) to monitor the progress and execution of our new business plan: (1) revenue; (2) order backlog; (3) pipeline growth; (4) deal closure time reduction; and (5) partner expansion,” said Sigma Additive Solutions president and CEO Jacob Brunsberg in the press release. “These are the KPIs we see as critical to achieving our business plan over the next two years. To be clear, we are focused on moving away from only selling an individual printer solution to supporting the additive industry, as a whole, at scale.”

To view the full press releases, visit https://ibn.fm/uXVGA and https://ibn.fm/9HDmu

About Sigma Additive Solutions

Sigma Additive Solutions is a leading provider of in-process quality assurance (“IPQA”) software to the additive manufacturing industry. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D(R) for 3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real time during the manufacturing process, enabling significant cost savings and production efficiencies by reducing waste, increasing yield and shortening cycle times. Sigma believes its software solutions will be a major catalyst for the acceleration and adoption of industrial 3D printing. For more information about the company, please visit www.SigmaAdditive.com.

NOTE TO INVESTORS: The latest news and updates relating to SASI are available in the company’s newsroom at http://ibn.fm/SASI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

ROTH Capital Partners, LLC (“Roth”), a full-service investment bank renowned for serving emerging growth companies, today announced that it will host the 11th Annual Roth Technology Event at the Yale Club in NYC on Nov. 16, 2022. The event will feature approximately 50 public companies operating within technology subsectors and provide investors with the opportunity to meet with and glean deep insights from respective executive management teams. “We have always focused our conferences on enabling participating companies to form a series of deep and meaningful relationships with a wide variety of investors,” said Byron Roth, chairman and CEO of Roth Capital Partners. “Technology, in its various forms, has become increasingly widespread in our daily lives. The 11th Annual Roth Technology conference will provide our analyst-picked list of small and mid-cap companies the opportunity to share insights and provide operational updates to the host of institutional investors that will be in attendance.”

To view the full press release, visit https://ibn.fm/2VDW9

About ROTH Capital Partners, LLC (“Roth”)

Roth is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, Roth provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, California, Roth is privately held and owned by its employees and maintains offices throughout the U.S. For more information, please visit www.Roth.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CubCrafters, a best-in-class backcountry aircraft producer, turned heads when it announced in July that it will make a public offering to raise investment capital through the sale of preferred stock. “Within the first 48 hours of its announcement, CubCrafters received $5 million in reservations for 1 million planned shares, which has grown beyond $20 million in reservations in the subsequent weeks as the company awaits qualification for its listing from the U.S. Securities and Exchange Commission (‘SEC’). The reservations for the company’s shares have taken off, rising closer and closer to its initial goal for the public offering,” a recent article reads. “‘As our company has grown, we’re the only company now doing four categories of airplanes. We’re doing Part 23 certified, experimental, builder-assist kits, as well as Light Sport,’ President and CEO Patrick Horgan told Aero-News Network in July… CubCrafters’ legacy stands in reviving the classic Piper PA-18 Super Cub light aircraft design with a completely modern approach over the past 40-plus years… The company has developed seven models that emphasize flexibility in options for backcountry exploration with landing gear configurations including nosewheel, tailwheel, floats, and skis.”

 To view the full article, visit https://ibn.fm/CJi2O

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL AN OFFERING STATEMENT FILED BY THE COMPANY WITH THE SEC HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

illimity Bank S.p.A.’s (“illimity” or the “Bank”) board of directors, chaired by Rosalba Casiraghi, has approved the illimity Group’s results as of Sept. 30, 2022. “Growth continued with the results for the third quarter. These are solid and in line with our forecasts, despite the fact that the scenario in which we operate has undergone a profound change since when we originally approved the budget,” said illimity CEO and Founder Corrado Passera. “illimity has been able to continue along its planned growth trajectory, which has enabled it to profitably affirm its various synergic core businesses on the market over a short period of time. The positive trend seen in 2022 will accelerate in the current quarter: October began with great momentum in terms of business origination and the advances in profitability dynamics will make it possible for us to end the year with a profit of at least 75 million euro, once again confirming our budget estimates. This is a result of particular interest because it includes important investments for the future. The three technological initiatives – b-ilty, Quimmo and Hype – have a combined effect of approximately 20 million euro in pre-tax losses; we expect that this negative result will drastically fall starting from 2023 and that the three initiatives will contribute to consolidated profit from 2024, creating significant value for the Group. We are also looking confidently at 2023: illimity has just successfully completed its fourth year of activity, and substantially completed its organizational structure. The business model has now become much more scalable thanks to the investments made and the critical size reached. Of particular satisfaction for all illimiters is the Best Place to Work certificate achieved at European level, as well as the flattering recognitions in ESG ratings.”

To view the full press release, visit https://ibn.fm/N87CQ

About illimity Bank S.p.A.

illimity is the high-tech banking group founded and led by Corrado Passera. A bank born without constraints, illimity is without the limits of the traditional system but with the solidity and seriousness of the best experiences. illimity provides credit to high-potential companies. For more information, visit www.illimity.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Viveve Medical (NASDAQ: VIVE), a medical technology company focused on women’s health and the treatment of female stress urinary incontinence (“SUI”), has reported its financial results for the third quarter 2022, the period ended Sept. 30, 2022. Highlights of the report include total revenue for the company reaching $1.7 million for the third quarter 2022, increasing the installed base of Viveve Systems to 915 worldwide, with 479 in the United States and 436 internationally; approximately 3,100 single-use disposable treatment tips sold globally; advanced 12-month follow-up visits in pivotal U.S. PURSUIT clinical trial for SUI targeting completion of final follow visits by the end of 2022 and reporting of topline data thereafter; and expanded IP as a result of the company’s reported notice of allowance for a second SUI method patent from the U.S. Patent and Trademark Office. Other financial numbers include total operating expenses for the quarter reaching $5.2 million, compared to $5.6 million for the same period in 2021, and net loss attributable to common stockholders for Q3 2022 reaching $6.3 million, or ($0.59) per share based on 10,655,410 weighted average shares outstanding during the period. The company also reported cash and cash equivalents of $5.9 million as of Sept. 30, 2022, down from $19.2 million as of Dec. 31, 2021. “During the third quarter of 2022, we continued to make great progress in the final phase of our pivotal U.S. PURSUIT clinical trial for the treatment of female stress urinary incontinence,” said Viveve Medical CEO Scott Durbin in the press release. “We remain on track to complete patient follow-up visits by the end of the year with topline results expected shortly thereafter. We are also pleased with our commercial results during the third quarter as we continue our ongoing efforts to increase adoption and utilization of the Viveve(R) System by core medical specialists in urology, urogynecology and gynecology in the U.S. and Asia Pacific regions.”

To view the full press release, visit https://ibn.fm/XgY9Q

About Viveve Medical Inc.

Viveve is a women’s health company focused on the treatment of female stress urinary incontinence (“SUI”). Based in Englewood, Colorado, the company is conducting a pivotal U.S. clinical trial called PURSUIT, using its novel, dual-energy treatment for SUI in women. The internationally patented Viveve(R) System incorporates cryogen-cooled monopolar radiofrequency technology to uniformly provide an endovaginal treatment that is nonablative. In the United States, the Viveve System is cleared by the U.S. Food and Drug Administration (“FDA”) for use in general surgical procedures for electrocoagulation and hemostasis. International regulatory approvals and clearances have been received for vaginal laxity and/or improvement in sexual function and/or urinary incontinence. Viveve’s current commercial and market development efforts focus on the U.S. and Asia Pacific regions targeting urogynecology, urology and gynecology core specialties. Viveve received FDA approval of its Investigational Device Exemption (“IDE”) application to conduct the multicenter, randomized, double-blinded, sham-controlled PURSUIT trial for improvement of SUI in women in July 2020, and FDA approval of its requested IDE protocol amendments in December 2020. The clinical trial was initiated in January 2021, and completion of subject enrollment was announced on Dec. 14, 2021. Completion of subject follow-up visits is anticipated by the end of 2022, and topline results will be reported shortly thereafter. If positive, results from the PURSUIT clinical trial may support a new SUI indication in the United States. For more information about the company, visit www.Viveve.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Save Foods (NASDAQ: SVFD), an agrifood tech company specializing in eco crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides, is featured in a RedChip Money Report(R) segment, slated to air on Bloomberg TV on Nov. 12, 2022, at 7 p.m. ET. During the interview, SVFD CEO of Israeli subsidiary Dan Sztybel chats about Save Foods’ commitment to reduce food waste and ensure food safety; he also discusses international market opportunities, provides an overview of commercial projects and pilot program successes, plus much more. Produced by RedChip Companies Inc., an international Investor relations and media firm, the RedChip Money Report is known for providing insightful commentary on small-cap investing as well as interviews with Wall Street analysts; the report also offers financial book reviews and featured interviews with executives of public companies.

To view the full report, visit https://ibn.fm/D9w01  

To view the full press release, visit https://ibn.fm/OtakU

About Save Foods Inc.

Save Foods is an innovative, dynamic company addressing two of the most significant challenges in the agrifood tech industry: food waste and loss and food safety. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and consumers alike. SVFD’s initial applications are in post-harvest treatments in fruit and vegetable packing houses that process produce such as citrus, avocado, pears, apples and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of hazardous chemicals and their residues, Save Foods treatments not only prolong fresh produce shelf life and reduce food loss and waste, but they also ensure a safe, natural, and healthy product. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company today announced that its CEO Dr. Faz Chowdhury will present a corporate overview at the Bernstein 2nd Annual CGM Disruptors Conference, which is being held virtually on Nov. 18, 2022. Dr. Chowdhury’s presentation is slated to begin at 10:30 a.m. Eastern Time on the day of the event.

To view the full press release, visit https://ibn.fm/jgKDA

About Nemaura Medical Inc.

Nemaura is a medical technology company developing and commercializing noninvasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT, a CE mark approved Class IIb medical device, is a noninvasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT to the U.S. FDA. proBEAT combines noninvasive glucose data processed using artificial intelligence and a digital health care subscription service that has been launched in the U.S. as a general wellness product as part of its BEAT(R) diabetes program that is currently undergoing pilot studies. The company sits at the intersection of the global type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023. For more information, visit the company’s website at www.NemauraMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Siyata Mobile (NASDAQ: SYTA) (TSX.V: SIM), a global vendor of Push-to-Talk over Cellular (“PoC”) devices and cellular signal booster systems, released an updated, corrected press release regarding its third quarter 2022 earnings. According to the announcement, the company’s third-quarter revenue increased by 11% year over year, totaling $2,567,885 compared to $1,218,875 for the same period in 2021; its adjusted EBITDA loss declined 68% year-over-year to an estimated $1.6 million; and increased purchase orders for the SYTA SD7 push-to-talk device and accessories increased during the quarter, resulting in revenues of approximately $1.4 million. “We are very pleased to report strong year-over-year and sequential top-line growth and declining losses for the third quarter of 2022,” said Siyata founder and CEO Marc Seelenfreund in the press release.

“Our improved financial performance was driven primarily by a number of customer trials of our SD7 rugged push-to-talk device, which began shipping in the second quarter, many of which then converted into purchase orders with volumes in Q3 that increased over Q2. Sales of our rugged devices and related accessories were up 588% year-over-year to $1.9 million in Q3, driven primarily by volume growth for our SD7. We delivered on our plan to build and expand our potential customers for the SD7 during the third quarter, providing us with a foundation of increased distribution that is directly leading to many potential significant volume opportunities, of which we have begun shipping products in an increasing number of verticals beyond our primary focus on first responders, including government, schools, utilities, security companies, defense contractors, amusement parks and hotel resorts, to name but a few. We are just beginning to see the rapid adoption of our disruptive solutions and as the displacement of land mobile radio (LMR) by PoC continues to progress, this should drive meaningful growth for our innovative products, such as the newest addition to our lineup, the SD7+, which integrates body-camera functionality with 4G cellular connectivity and PoC features in a single solution.”

To view the full press release, visit https://ibn.fm/IjaPC

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation Push-to-Talk over cellular (“PoC”) devices and cellular booster systems. Its portfolio of in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice to increase situational awareness and save lives. Siyata’s portfolio of enterprise-grade and consumer cellular-booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for maximum cellular signal strength possible. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that has developed new-generation power electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries, has released an operational update in conjunction with the filing its financial results for the nine months ended Sept. 30, 2022. Highlights of the update note that the company is on schedule for key deliverables and milestones for the next quarter, including the delivery of a prototype e-axle to Linamar as well as pilots with Vicinity and SEA Electric and ISO certification by the end of the year. The update noted that the initial deliveries of its Coil Driver(TM) for series production is slated to begin in third quarter 2023 and its Cell Driver(TM) is on schedule for completion of UL certification requirements in second quarter 2023. The company also reported that, following a capital raise of approximately $9.8 million earlier this year, it is closing Q3 2023 with approximately $13.1 million in cash.

“We are energized, we are focused, and we are determined,” said Exro Technologies CEO Sue Ozdemir. “Our Q3 results demonstrate Exro’s tenacity to continue to advance our products, our partnerships and our business through a challenging macro environment. Despite interim delays with various items, our team has worked hard to execute and deliver. Thanks to these efforts, we remain on track for all key deliverables in Q4 2022 and, importantly, for start of production in Q3 2023. While bringing new technology to market is never easy, and there are bound to be challenges ahead, internally we are excited by the potential the next several quarters hold for our business and shareholders. Our Coil Driver is derisked and moving into customer vehicles, our Cell Driver energy storage is scheduled for UL certification in Q2 2023, and the demand we are seeing for our products is promising. We look forward to keeping our shareholders updated regularly on our progress on their behalf.”

To view the full press release, visit https://ibn.fm/1x1nR

About Exro Technologies Inc.

Exro is a clean technology company pioneering intelligent control solutions in power electronics to help solve the most challenging problems in electrification. Exro has developed a new class of control technology that expands the capabilities of electric motors, generators and batteries. Exro enables the application to achieve more with less energy consumed. The company’s advanced motor control technology, the Coil Driver, expands the capabilities of electric powertrains by enabling intelligent optimization for efficient energy consumption. Exro is working with many partners from all over the world to bring its technology to the electric mobility industries and beyond. For more information about the company, please visit www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is reporting corporate updates and financial results for its Q3 quarter, ended Sept. 30, 2022. According to the announcement, the report reflects revenue growth and increased gross profit margin as compared to prior year periods. Highlights of the report include notice that a new CEO and chair, Raymond F. Vennare, was named, along with other key team member appointments; the company also continues to attract potential partners with its breakthrough solution that enables pharmaceutical and biotech companies to advance drug development and accelerate time to market. The report noted that POAI is leveraging its novel platform technology by pairing with the largest privately held biobank of more than 150,000 tumor samples to help drug developers make higher confidence predictions that ultimately lead to greater chances of commercial success. The company also noted that its GMP lab is available to help clients move from preclinical drug development to the investigational new drug qualification. Financial numbers worth noting include revenue of $455,827, which is a 45% increase from $313,663 reported in the same period in 2021; Helomics reported an improvement in its net losses; and the company’s gross profit grew 76% compared to 65% in the comparable 2021 period. R&D costs came in at $116,763 for the quarter, down from $234,357 in the quarter ended Sept. 30, 2021, with general and administrative expenses totaling $3,287,918.

To view the full press release, visit https://ibn.fm/YOFiy

About Predictive Oncology Inc.

Predictive Oncology is a science-driven company focused on applying artificial intelligence (AI) to develop optimal cancer therapies, which can lead to more effective treatments and improved patient outcomes. Through AI, Predictive Oncology uses a biobank of 150,000-plus cancer tumors, categorized by patient type, against drug compounds to help the drug-discovery process and increase the probability of success. The company offers a suite of solutions for oncology drug development from early discovery to clinical trials. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, is identifying an additional $5 million in potential savings; the savings come from planned implementation of cost savings and expected margin enhancements. The company is focused on its Pathway to Profitability and has estimated a total $20 million in savings will be achieved throughout fiscal years 2023 and 2024. The company also announced that it anticipates record revenue will be posted in its Q2 2023 financial earnings report, which will be released on Nov. 14, 2022, after the U.S. market closes. “The Alkaline Water Company continues to find ways to be more efficient while maintaining strong sales momentum in pursuit of our ultimate goal of becoming a profitable company,” said The Alkaline Water Company president and CEO Frank Lazaran in the press release. “We have now identified approximately $20 million in total savings and margin improvement compared to last fiscal year. Though it will take time to see the full benefits of the measures we’re taking to improve our bottom line, we look forward to sharing with our shareholders next week the early progress we’ve made in our first full quarter on our Pathway to Profitability.”

To view the full press release, visit https://ibn.fm/spQ4f

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with ecofriendly aluminum packaging options. With its innovative, state-of-the-art, proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked Clean Beverage label. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and as a celebrity brand ambassador for the Alkaline88 and A88 Infused brands. To learn more about the company, please visit www.Alkaline88.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

VistaGen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, is reporting its financial results and corporate highlights for fiscal year 2023, the period ended Sept. 30, 2022. Among the highlights include news that an independent analysis of VTGN’s PALISADE-2 phase 3 study evaluating social anxiety disorder (“SAD”) recommends continuing the study and that analysis of nearly 400 subjects in the final data set for a second study, the PALISADE open label study, showed participants exhibiting robust functional improvement in anxiety-provoking social and performance situations; the report also noted that VistaGen anticipates meeting with the U.S. Food and Drug Administration to discuss the next step in phase 3 development of its PH94B in the treatment of SAD. Financial numbers of note include an increase in R&D of $2.9 million, up from $10 million for the same quarter in 2021 to $12.9 million for the quarter ended 2023; general and administrative expense also increased, reaching approximately $3.7 million for the quarter with net loss attributable to common stockholders for the fiscal quarters ended Sept. 30, 2022 and 2021, being approximately $17.5 million and $13.2 million, respectively.

“During the past quarter, VistaBen achieved several important milestones to advance our CNS pipeline,” said VistaGen Therapeutics CEO Shawn Singh in the press release. “Recent independent data analysis supports our work to restart our PALISADE-2 phase 3 study of PH94B in social anxiety disorder, and preliminary data from nearly 400 subjects in our PALISADE open label study demonstrate that PH94B has potential to help millions of individuals suffering from social anxiety disorder, without the side effects and safety concerns often associated with prior FDA approvals in SAD and other off-label treatment options. We are focused on optimizing clinical studies for PH94B, and we will soon meet with the FDA to pursue a consensus path forward in our Phase 3 program in social anxiety disorder. We are also advancing our second pherine asset, PH10. We recently submitted our U.S. Investigational New Drug application for a small phase 1 study to facilitate entering phase 2B development of PH10 in major depressive disorder. Both therapies have the potential to offer novel, fast-acting treatment for millions of patients confronting the effects of debilitating mental health challenges.”

To view the full press release, visit https://ibn.fm/KXTE0

About VistaGen Therapeutics Inc.

VistaGen is a late clinical-stage CNS-focused biopharmaceutical aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than those that are currently available. Vistagen’s clinical-stage candidates are targeting multiple forms of anxiety and depression. Candidates include PH94B and PH10, which belong to a new class of drugs known as pherines, which are investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression — one mind at a time. For more information about the company, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Lottery.com (NASDAQ: LTRY), a global tech company delivering trusted gaming solutions wherever lotteries are played, has announced changes in key board roles. The company announced that Matthew H. McGahan, an existing director, has been appointed chair of the board; the company also named two new board members: Barney Battles and Naila Chowdhury. Noting that these appointments come at a transformation time for the company, the announcement outlined McGahan’s vast experience in working with turnarounds and distressed projects, including his family’s own Pinewood Motor Group. Other key accomplishments included becoming the first dealer to bring Toyota Motor Corporation to the United Kingdom and founding Magic Automotive Group, which grew into one of the largest Harley-Davidson and BMW dealerships in Europe. McGahan also is a successful investor, building a sizeable portfolio that included investments in several sectors including property, motorsports, EV, technology, minerals, mining, recycling, fintech and medical research. He also founded the UK charity Mask Our Heroes, created in memory of his father, who died of COVID-19 pandemic. Battles founded the League of Angels and is the former co-owner of Jackpot Games, a Maltese online gaming venture that was sold to a large German media group, and former senior advisor to the Rank Group PLC, where he focused on Grosvenor Casinos and Bingo. Chowdhury has garnered more than two decades leadership experience in senior management in private, public, and nonprofit organizations globally, including as cofounder and former CEO of Pillar 4 Dignity, which supports and empowers underserved women and girls worldwide who face social and economic challenges. “I would like to welcome all the new directors to the board and am delighted at Matthew’s appointment to chairman,” said Lottery.com CEO Sohail Quraeshi in the press release. “Each of them brings considerable and relevant experience, which will substantially enhance our senior leadership team, compliance, CSR and strategic capability. These appointments are a crucial next step as we complete the turnaround of the business and implement a strategy for future growth.”

To view the full press release, visit https://ibn.fm/IS2Ru

About Lottery.com 

Lottery.com is a leading technology company that is transforming how, where and when lotteries are played. Its engaging mobile and online platforms enable players located in the United States and other countries to remotely purchase safe and legal lottery games. Lottery participants look to Lottery.com for compelling, real-time results on more than 800 lottery games from more than 40 countries. Additionally, through WinTogether.org, Lottery.com is fundamentally changing how nonprofit donors are incentivized to action by gamifying charitable giving. In all that it does, Lottery.com’s mission remains the same: an uncompromising passion to innovate, grow a new demographic of enthusiasts, deliver responsible and trusted solutions, and promote community and philanthropic initiatives. To learn more about the company, visit www.Lottery.com.

NOTE TO INVESTORS: The latest news and updates relating to Lottery are available in the company’s newsroom at https://ibn.fm/Lottery

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

ROTH Capital Partners (“ROTH”), a full-service investment bank focused on serving emerging growth companies and their investors, today announced that it will host its 2nd Annual AgTech Answers Conference in New York City on Nov. 15, 2022. The event will provide pre-qualified institutional investors and industry professionals the opportunity to closely interact with C-level executives of approximately 20 public and private AgTech companies selected by ROTH’s research analysts. “Our conferences provide unique opportunities for meaningful conversations and fostering relationships between companies and a wide spectrum of investors,” said ROTH’s Managing Director of AgTech Investment Banking, Ivan Saval. “At ROTH, we pride ourselves as one of the leaders in capital formation and advisory services for growth-oriented companies. Imagery, biologicals, indoor farming, precision agriculture, crop protection and protein technologies are among the most promising, exciting and necessary areas in the AgTech industry today. Institutional investors will benefit from the fireside chat presentations and 1×1 meetings, insights and operational updates from the select small and micro-cap companies as well as private companies showcased during this event.”

To view the full press release, visit https://ibn.fm/v5wIn

About ROTH Capital Partners, LLC (“ROTH”)

ROTH is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, California, ROTH is privately held and owned by its employees and maintains offices throughout the U.S. For more information, please visit www.ROTH.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Amesite (NASDAQ: AMST), which harnesses cutting-edge artificial intelligence (AI) to deliver customizable courses through its white-label platform, is releasing the results of a recent study conducted in cooperation with EWIE Group of Companies (“EGC”), a large company that used Amesite’s technology to upskill its global workforce. Amesite and EGC partnered to provide an eLearning solution that would help ECG retail and upskill employees around the world. AMST provided learning tools that would encourage employee engagement among nearly 1,000 employees working at more than 240 factories around the globe. The tools needed to be accessible to all employees and integrate across all platforms. Leveraging its customized Learning Community Environment(R) (“LCESM”), Amesite rolled out 53 courses in four days, created to meet the specific needs of the EGC workforce. Results show that before the end of the first quarter, employees were scoring 91% on the learned material; a target passing score had been identified as 70%. AMST’s white-label system can be customized for specific educational needs and its AI provides updated information for learners, all within an intuitive, easy-to-navigate infrastructure. “Having people with the most advanced skills is a huge competitive advantage for us,” said EWIE Group of Companies president Jay Mullick in the press release. “Amesite is at the center of all our business process training at EGC. We have appreciated the support of their team throughout the relationship. Using Amesite’s global upskilling technology platform enables our people to gain the know-how to meet our most demanding customers’ needs quickly and efficiently.”

To view the full press release, visit https://ibn.fm/mNACD

About Amesite Inc.

Amesite is an artificial-intelligence-driven platform and course designer that provides online products in the United States. The company uses machine learning to offer a mass customized experience to learners. Its customers include businesses, universities and colleges, K-12 schools, and nonprofit organizations. The company was incorporated in 2017 and is headquartered in Detroit, Michigan. For more information about the company, please visit www.Amesite.io.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, is anticipating record revenue of $19.6 million in its upcoming second quarter 2023 report; that figure represents an increase of 28% over last year’s numbers. According to the announcement, data from Nielsen, a third-party source, indicates that Alkaline88(R)grew 36.6% year-over-year in dollar volume, a rate that is more than 2.5 times higher than the average in the value-added water category. Nielsen also reported that the value-added water category was the second-fastest-growing category, leading all categories except for water. The announcement also observed that during the last 13 weeks, retail sales totaled more than $26 million. In addition, the company announced that it will report full results for Q2 2023 on Nov. 14, 2022, after the U.S. market closes. Key members of WTER’s management team are scheduled to host a conference call to discuss the results during an earnings conference call slated for Nov. 15, 2022, at 8:30 a.m. ET. Those in the United States and Canada who are interested can dial in by calling 877-407-3088; international callers can dial 201-389-0927. All callers will use the conference ID number 13734370. “The second quarter fiscal 2023 was The Alkaline Water Company’s best sales quarter ever,” said The Alkaline Water Company president and CEO Frank Lazaran in the press release. “Alkaline88(R) continues to show strong growth at retail, with more consumers buying our products at more stores across the country than ever before, and that has translated into record revenue for the company. . . . The Alkaline Water Company has grown to record revenue while increasing operational efficiency by executing our pathway to profitability strategy. We look forward to sharing the full results of this record quarter with our shareholders next week.”

To view the full press release, visit https://ibn.fm/q8E4P

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with ecofriendly aluminum packaging options. With its innovative, state-of-the-art, proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked Clean Beverage label. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and as a celebrity brand ambassador for the Alkaline88 and A88 Infused brands. To learn more about the company, please visit www.Alkaline88.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has announced the Nov. 9, 2022, dismissal of the claim for USD $30.2 million brought by the company’s former CEO, Dr. Raza Bokhari. Dr. Bokhari had claimed that he had been wrongfully dismissed. The arbitrator hearing the claim dismissed it in its entirety and ordered Dr. Bokhari to repay certain monies to FSD Pharma, while also holding Dr. Bokhari responsible for FSD Pharma’s costs of the arbitration. “The outcome of the arbitration represents a full vindication of the actions of the current management and board of directors of FSD Pharma with respect to Dr. Bokhari, prior to, during and subsequent to the 2021 proxy battle,” said Zeeshan Saeed, founder, president and executive co-chairman of the company. “We are happy to report to our shareholders that this claim has been resolved fully in our favour.”

To view the full press release, visit https://ibn.fm/qG5Nf

About FSD Pharma Inc.

FSD Pharma is a biotechnology company with three drug candidates in different stages of development. FSD BioSciences Inc., a wholly owned subsidiary, is focused on pharmaceutical research and development of its lead compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases. Lucid Psycheceuticals Inc., a wholly owned subsidiary, is focused on the research and development of its lead compounds, Lucid-Psych and Lucid-MS. Lucid-Psych is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. For more information, visit the company’s website at www.FSDPharma.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

FE Battery Metals Corp. (CSE: FE) (OTCQB: FEMFD), a publicly traded Canadian mineral exploration company, is reporting on its phase 2 exploration work of the Augustus property. Phase 2 includes prospecting, mapping, sampling and diamond core drilling. According to the update, FE Battery Metals has completed eight NQ size core drill holes on the property, including cumulative drilling of more than 2,200 meters for this phase; the report noted that, since 2021, First Energy has completed more than 8,000 meters of diamond drilling on the property. “During the current prospecting work, several pegmatites were identified by the field team on Sayona North claim block located to the northwest of the Authier deposit of Sayona Mining,” wrote CEO and director Gurminder Sangha in the report. “One drill hole from the phase 2 work was drilled to intersect a pegmatite on this block to assess its potential to host lithium mineralization. The drill core from this program was logged and sampled at the core shack located about 50 km from the property in the village of St-Dominique du Rosaire. The samples were bagged and tagged using best practices and were delivered to Activation Laboratories, Ancaster, Ontario, for sample preparation and analyses.”

To view the full press release, visit https://ibn.fm/X7Djg

About FE Battery Metals Corp.

FE Battery Metals is a Canadian mineral exploration company with a primary focus of acquiring mineral properties in the battery metal sector. The company’s goal is to identify, acquire and explore North American mineral prospects with a primary focus on lithium. It’s strategy is to acquire and advance projects through prospecting and early-stage exploration; source joint venture partners to finance future exploration and project development; and create shareholder value through exploration success. For more information about the company, please visit www.FirstEnergyMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that the company’s collaborators from the University of Michigan will present two scientific posters in the upcoming Society for Neuroscience (“SfN”) Conference. The event is slated to take place from Nov. 12-16, 2022, in San Diego. “We are excited our collaborators at the University of Michigan are presenting the results of our two recent studies. The first study explored intravenous psilocybin and its effect in a recognized rat model of fibromyalgia. This model exhibits increased sensitivity to touch and hypersensitivity to elevated temperatures. Administration of a single intravenous infusion of psilocybin resulted in a decrease in both pain and heat sensitivity persisting until the end of the study (28 days). Tryp is the first company to pursue the use of psychedelics in nociplastic pain indications including fibromyalgia. These results support the potential clinical utility of psilocybin assisted therapy in the treatment of patients with fibromyalgia,” said Tryp’s CEO Jim Gilligan. “The second study demonstrated a change in EEG recordings coincident with achieving the psychedelic state. Rats received a continuous intravenous infusion of psilocybin over a period of 60 minutes while EEG data were simultaneously monitored. The results demonstrate the ability to detect changes in EEG patterns coincident with attaining the psychedelic state. In addition, upon cessation of the infusion a return to baseline EEG patterns correlated with decreasing blood levels of psilocin. This study will help facilitate Tryp’s program to utilize EEG recordings to optimize dose and infusion rates of TRP-8803 (IV psilocin) in planned upcoming clinical trials.”

To view the full press release, visit https://ibn.fm/WY8Sv

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing psilocybin-related molecules, including TRP-8803, for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. Tryp’s Psilocybin-for-Neuropsychiatric Disorders (PFN(TM)) program is focused on the development of synthetic psilocybin-related molecules as a new class of drug for the treatment of binge eating, chronic pain and other indications. The company has begun enrolling patients in its phase II trial for the treatment of binge eating disorder at the University of Florida and recently announced an upcoming phase IIa clinical trial with the University of Michigan to evaluate TRP-8802 for fibromyalgia. TRP-8803 is a proprietary psilocybin-based product that uses a novel formulation and route of administration to potentially improve efficacy, safety and the patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nextech AR Solutions (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), a metaverse company and leading provider of augmented reality (“AR”) experience technologies, wayfinding technologies and 3D model services, is seeing record demand for its 3D models; the company anticipates this trend to continue well into 2023 and beyond. Noting that 3D model trends are only gaining traction, the company has consistently announced the closing of new 3D modeling deals for ecommerce and is seeing robust renewals and reorders. According to the announcement, Nextech has had renewals and reorders in an array of sectors, including e-commerce sites, specialty products, sports equipment and home goods. The company has signed new contracts in the flooring, specialty outdoor furniture/equipment and partner agency spaces. The company anticipates releasing its Q3 2022 earnings report after market close on Nov. 17, 2022, and has scheduled an earnings call and webinar for the same day, to begin at 5 p.m. ET. Nextech CEO Evan Gappelberg and Nextech CFO Andrew Chan will host the event and will discuss the company’s financial and operating results; the call will also include a Q&A session. Those interested can call 1-888-330-2024 or 1-646-960-0187 (internationally); all callers should use the conference ID 7778367. Following the presentation, a recording of the webinar will be available on the company’s IR website.

To view the webinar, visit https://ibn.fm/bMwyo

To view the full press release, visit https://ibn.fm/7mx0G

About Nextech AR Solutions Corp.

Nextech AR Solutions is the engine accelerating the growth of the metaverse. Using breakthrough artificial intelligence (“AI”), Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, and giving creators at every level all the essential tools they need to build out their digital AR vision in the metaverse. The company’s platform-agnostic tools allow brands, educators, students, manufacturers, creators and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments; compose AR experiences; and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D commerce, education, events and industrial manufacturing, Nextech AR is in a unique position to meet the needs of the world’s biggest brands and all metaverse contributors. On October 26, 2022 Nextech AR spun out its spatial computing platform, ARway Corp., as a standalone public company. Nextech AR retained a control ownership in ARway Corp. with 13 million shares, or a 50% stake. ARway is disrupting the augmented reality wayfinding market with a no-code, no-beacon spatial computing platform enabled by visual marker tracking. For more information about the company, please visit www.NextechAR.com.    

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vision Hydrogen (OTCQB: VIHDD), a renewable energy company developing carbon-reduced hydrogen solutions for the commercial, industrial and transportation sectors, is partnering with Linde plc (NYSE: LIN) to fast-track its work on the Green Energy Terminal in North Sea Port of Vlissingen, the Netherlands. The cooperation agreement calls for Evolution Terminals BV, VIHDD’s wholly owned subsidiary, to work with Linde in delivering preliminary front-end engineering and design (“FEED”) services for the pioneering project. Those FEED services will include the design and engineering for storage of 150,000 cubic meters of green ammonia (“NH3”) as well as loading facilities for trucks, barges and ships; the two companies will also work on utilities, infrastructure and buildings. The two companies have already started working together, and their efforts are anticipated to extend through the project final investment decision (“FID”) phase, which is slated for approximately April 2023. According to the announcement, Vision Energy is already in the advanced stages of planning for the project, which will be northwestern Europe’s first import, storage and handling terminal designed exclusively for hydrogen carriers, renewable energy products and low-carbon fuels. Linde is a leading global industrial gases and engineering company, Linde reported sales of $31 billion in 2021 as it serves a variety of end markets including chemicals & energy, food & beverage, electronics, healthcare, manufacturing, metals and mining. “Our cooperation with Linde Engineering marks a critical milestone in our development, to deliver this world-class project with the vast global expertise Linde possesses,” said Vision Hydrogen CEO Andrew Hromyk in the press release. “Our Green Energy Terminal Project will accelerate and advance the energy transition and facilitate Northwestern Europe’s ambition to achieve Net Zero through carbon-abatement and adoption of hydrogen as a core feedstock and fuel.”

To view the full press release, visit https://ibn.fm/7yXuD

About Vision Energy Corporation

Vision Energy is an integrated energy company developing assets and solutions for the commercial, industrial and transportation sectors. The company is leveraging its proven track record in site and asset procurement, accelerating development and permitting processes, plant design, and grid integration to facilitate low-carbon energy production, supply and distribution. The company pursues reliable offtake relationships and operating partnerships with energy industry participants and end users seeking carbon abatements across feedstock and fuels. Vision Energy is committed to providing low carbon energy solutions with the highest yield, and where possible, projects are designed to leverage existing gas and power infrastructure to integrate and facilitate import and or distribution of reduced-carbon energy to domestic and global supply chains. For more information about the company, visit www.VisionEnergy.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, is announcing changes to its board of directors and management team. According to the announcement, both Yuyang Cui and Jiawen Kang have resigned. Cui was serving as cochair of the board and co-CEO; Jiawen Kang served as a director of the board, a member of the audit committee and a member of the nominating and corporate governance committee. Both resignations were effective earlier this week. “On behalf of the board of directors and management team, I would like to express our sincere gratitude to them for all their contributions to the company,” said AnPac Bio-Medical Science cochair and co-CEO Haohan Xu in the press release.

To view the full press release, visit https://ibn.fm/t3Nuz

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. According to a report by Frost & Sullivan, AnPac Bio ranked first globally in multicancer screening and detection-test sample volume, accumulative to January 2021. AnPac Bio’s CDA technology platform has been shown in retrospective validation studies to be able to detect the risk of more than 20 different cancer types with high sensitivity and specificity. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), a leading pre-commercial lithium project development company, today reported its financial and operating results for the fiscal first quarter ended Sept. 30, 2022. “Q1 was an important quarter for Standard Lithium, in which we advanced our development strategy in meaningful ways – and have continued this momentum into the current quarter,” said the company’s CEO and Director Robert Mintak. “We achieved milestones, the most significant of which was awarding the Front-End Engineering and Design (‘FEED’) and Definitive Feasibility Study (‘DFS’) for our first commercial lithium plant. That work is successfully underway, with trade-off studies being completed, and the FEED and DFS for Phase 1A on schedule for delivery in the first half of 2023 and will be summarized in a NI 43-101 DFS report.”

To view the full press release, visit https://ibn.fm/PCUjU

About Standard Lithium Ltd.

Standard Lithium is a leading pre-commercial lithium development company with a portfolio of projects in process. The company’s flagship projects, the LANXESS Property Project and the South-West Arkansas Project, are located in southern Arkansas near the Louisiana state border. The company is focused on the evaluation and testing of commercial lithium extraction and purification from brine sourced from approximately 180,000 acres of unitized leases across these two projects. The company operates a first-of-a-kind industrial-scale Direct Lithium Extraction (“DLE”) Demonstration Plant at the LANXESS Property Project. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. A Definitive Feasibility Study (“DFS”) and Front-End Engineering Study (“FEED”) for Phase 1A of the LANXESS Property Project commenced in September 2022. A Preliminary Feasibility Study (“PFS”) of the South-West Arkansas Project commenced in May 2022. The company is also pursuing the resource development of approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California. Standard Lithium is jointly listed on the TSX Venture Exchange and the NYSE American under the trading symbol SLI and on the Frankfurt Stock Exchange under the symbol S5L. For more information, please visit the company’s website at www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has announced a name change. According to the company, effective next Monday, Nov. 14, 2022, the company’s name will change from XPhyto Therapeutics Corp. to BioNxt Solutions Inc. Along with the name change, the company’s trading symbol will change to BNXT from XPHY. The company will continue to focus on developing next-generation drug formulations and delivery systems and diagnostic screening tests and look for active pharmaceutical-ingredient investment opportunities. The company has R&D facilities in North America and Europe and is working on gaining regulatory approval and moving toward commercialization of medical products for European markets.

To view the full press release, visit https://ibn.fm/uPjpq

About BioNxt Solutions Inc.

BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities. These opportunities include precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets. For more information about the company, visit www.XPhyto.com.

NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at https://ibn.fm/XPHYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, is reporting on its Q3 2022 financial and operating results for the period ended Sept. 30, 2022. Highlights of the report includes revenue for the quarter reaching $24.3 million as well as subsidiaries Energica providing 88 electric motorcycles for the upcoming G20 Summit Indonesia and US Hybrid supplying proprietary electric and hybrid electric propulsion kits for use in 62 zero-emission street sweepers constructed by Global Environments Products (“GEP”). In addition, the company gained 11 new dealer partnerships during the quarter, partnered with Nolan Manufacturing to produce Solectrac’s e25 electric tractors; entered an agreement with ABC Companies, a leading provider of motorcoach, transit and specialty passenger transport equipment in North America, to become a certified reseller of WAVE’s industry-leading wireless inductive charging technology; and successfully tested WAVE’s 500kW wireless charger at the Port of Los Angeles. IDEX also unveiled a product design studio created to build a new generation of high-performance electric mobility and charging solutions and named Stephen Johnston as its new CFO. The company also announced that Energica, through its Energica Inside business unit, and Solectrac are collaborating on a new generation of electric tractors. Energica Inside will provide Solectrac with battery-pack and vehicle-control-unit development as well as prototype assembly and testing. The collaboration should improve run-time, enabling customers to do more with their electric tractors per charge. “In the third quarter, Ideanomics showed the value and strength of our growing EV businesses, highlighted by Energica’s deal to provide motorcycles for the Indonesian National Police, which will be utilized at the upcoming G20 summit,” said Ideanomics CEO Alf Poor in the press release. “Solectrac, like Energica, is also experiencing demand-based growth and has expanded its manufacturing capacity resulting in a significant increase in unit production, while US Hybrid is on track towards profitability by the end of 2023. Furthermore, our WAVE business secured its first fleet customer in Q3. We look forward to continuing to demonstrate how our differentiated products and technologies drive revenue growth across our EV brands.”

To view the full press releases, visit https://ibn.fm/TGxyr and https://ibn.fm/lXuUD

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: to accelerate the commercial adoption of electric vehicles. By bringing together vehicles and charging technology with design, implementation, and financial services, we provide the completeness of solutions needed for the commercial world to commit to an EV future. For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Sharing Services Global (OTCQB: SHRG) is dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. “SHRG announced the rebranding of its direct-sales division in March 2021, noting that the newly titled brand [the Happy Company] had received a $30 million investment increase from its largest shareholder, Document Security Systems. In addition, SHRG announced plans to launch a travel company to add to its direct-selling arsenal, focusing on providing exclusive benefits and first-class discount travel opportunities to its brand partners and customers,” a recent article reads. “We will be in the right place at the right time on our launch of Hapi Travel Destinations. All the pieces for a successful launch are falling into place as consumers are starting to re-engage with travel, hospitality and vacations on a regular basis,” SHRG CEO John ‘JT’ Thatch is quoted as saying at time of the launch. “Our hope is that this turnkey travel solution we’ve created will open up travel opportunities for so many consumers who were previously only able to dream about grand adventures.”

To view the full article, visit https://ibn.fm/UzFu5

About Sharing Services Global Corporation

Sharing Services is a publicly traded company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling sector and other industries. Sharing Services’ combined platform currently leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors. For more information, visit www.SHRGInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, is reporting its unaudited financial results for the third quarter ended September 30, 2022. Notable numbers from the report include a decrease in revenues, down from $87 million in Q3 2021 to $78.8 million in Q3 2022 and an increase in operating costs, which totaled $124.1 million in third quarter 2022, up from $59.2 million for the same period last year. The company noted that the increase came primarily from a $70.25 million charge related to the settlement of a class action and associated proceedings. In addition, the report noted that adjusted EBITDA decreased from $30.2 million for Q3 2021 to $25 million for the Q3 2022, resulting in an adjusted EBITDA margin of 31.7% for the third quarter of 2022. Net income was down — a reported $24 million loss — while the average revenue per daily active user (“ARPDAU”) remained consistent from year to year. “DoubleDown generated solid results in the third quarter of 2022 with another quarter of positive free cash flow and adjusted EBITDA margin being above 30%, demonstrating the stickiness of our customer base and long-term engagement by our players,” said DoubleDown CEO In Keuk Kim in the press release. “Revenue in the third quarter of 2022 was 14% higher than the third quarter of 2019, the most recent comparable period prior to the COVID pandemic, which we believe validates our success in capturing and retaining growth in our customer base and player spending over the past few years. Further, we were able to maintain our ARPDAU and average monthly revenue per payer metrics from the year-ago period, despite global inflationary pressure and recession concerns that have impacted player behavior, demonstrating the resilience of our business.”

To view the full press release, visit https://ibn.fm/Zeb1U

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. For more information about this company, please visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing space, today announced that its CEO Matthew Moore was invited to present at the Emerging Growth Conference. Moore is scheduled to present at 1:10 p.m. ET on Wednesday, Nov. 9, 2022, and will highlight the numerous revenue opportunities for InnerScope’s HearingAssist and iHear OTC hearing aid brands since the OTC law was enacted on Oct. 17, 2022. The live, online conference will allow existing shareholders and the investment community to interact with InnerScope’s CEO in real time. Interested parties should visit https://ibn.fm/QKccs to register for the event and receive updates. An archived webcast will be made available on EmergingGrowth.com for those unable to join the event live on the day of the conference.

To view the full press release, visit https://ibn.fm/ceemr

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s hearing products and its B2C and B2B business model break through the persistent barriers that prevent access to effective and affordable hearing solutions. InnerScope’s recent acquisition of iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, gives the company access to over 40 patents and an R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced hearing products through Walmart and many other major retailers and pharmacy chains. InnerScope’s full line of hearing products is currently available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, RiteAid.com, BestBuy.com, Amazon.com, Fingerhut.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, Cardinal Health(TM) at-Home, and Topco Associates, representing 1000’s of stores. More in-store and online hearing products will soon launch with other major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced it would release its financial results for the third quarter ended Sept. 30, 2022, after markets close on Monday, Nov. 14, 2022. The company will host a conference call and webcast at 8:30 am Eastern Time on Tuesday, Nov. 15, 2022, led by its Chief Executive Officer Erez Raphael, GM of North America and President Rick Anderson, and Chief Financial Officer Zvi Ben-David. Interested parties should visit https://ibn.fm/w2MdP to register for and access the webcast and may join the call by dialing 1-844-826-3035 or 1-412-317-5195 (international) and submitting conference ID: 10173311 and conference title: DarioHealth Corp. – Third Quarter 2022 Results Call. Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion as detailed in the news release.

To view the full press release, visit https://ibn.fm/D3g9N

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Siyata Mobile (NASDAQ: SYTA) (TSX.V: SIM), a global vendor of Push-to-Talk over Cellular (“PoC”) devices and cellular signal booster systems, has announced that it will report its third quarter 2022 numbers after market close on Nov. 10, 2022. In addition, the company has scheduled a conference call to discuss its financial report. The call will be held on Nov. 11, 2022, at 8 a.m. EST. The call will include a formal presentation by key management team members, who will then participate in a Q&A session. Individuals interested in participating on the call can dial 1 (416) 764-8658 in North America or 1 (888) 886-7786 internationally. In addition, the company will provide a replay of the call, available in MP3 format, available through its investor relations.

To view the full press release, visit https://ibn.fm/1Zz4c

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation Push-to-Talk over cellular (“PoC”) devices and cellular booster systems. Its portfolio of in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice to increase situational awareness and save lives. Siyata’s portfolio of enterprise-grade and consumer cellular-booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for maximum cellular signal strength possible. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content distributor, today announced that IoT Events has engaged its NetworkNewsWire (“NNW”) brand as the official newswire for the upcoming Intelligent Cities Canada 2022 (“Intelligent Cities“). In addition, IBN will serve as the corporate communications firm for the summit. Intelligent Cities, to be held in a hybrid format at BMO IFL in Toronto, Ontario, on Nov. 9-10, 2022, encapsulates four summits addressing the challenges faced by public sector professionals and strategies for deploying cutting-edge technology to improve citizen services. As the official newswire for the event, NNW will combine traditional wire-grade press release dissemination alongside article syndication. As the corporate communications firm, IBN will leverage its array of state-of-the-art solutions to increase the visibility and further the outreach of key speakers and exhibitors via extensive digital channels and multi-brand social media capabilities. “IoT Events is a global leader in exploring how next-generation technologies such as AI can optimize public service delivery to citizens and drive public sector efficiency,” said Jonathan Keim, communications director for IBN. “Given recent events around the world, municipalities face a number of unique challenges. For IBN, it is a great opportunity to collaborate with the IoT Events team while making a meaningful contribution to the discourse in these areas.”

To view the full press release, visit https://ibn.fm/SGBxT

About InvestorBrandNetwork

IBN consists of a Dynamic Brand Portfolio (“DBP”) introduced to the investment public over the course of 15+ years. Through this portfolio of brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (“IW”) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.

For more information on IBN, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Creatd (OTCQB: CRTD), a creator-first company, has begun the application process to dual-list its shares on Upstream, the premier global exchange and trading app for digital securities and NFTs; Upstream is powered by Horizon Fintex and MERJ Exchange Limited. Creatd noted that is anticipates the Upstream listing will provide access to a global, digital-first investor base; through Upstream, investors can trade using USDC digital currency along with credit, debit, PayPal and USD. According to the announcement, the listing should unlock liquidity and enhance price discovery while globalizing the opportunity to invest in Creatd as the company prepares to relist on a national exchange. Approval to be listed on Upstream is subject to approval by MERJ. “Upholding transparency is what will drive the next stage of evolution in the public markets,” said Creatd CEO Jeremy Frommer in the press release. “Upstream is uniquely leading this charge by combining the best available technology with enforcement practices that together work to protect and empower issuer and investor alike. We are pursuing Creatd’s dual listing as part of a broader effort to realize the true value of our stock. Looking ahead, we are enthusiastic about the other potential opportunities to leverage Upstream, including its potential utility for the proposed spinoff of our OG Collection media library and other monetizable assets.”

To view the full press release, visit https://ibn.fm/eaVV7

About Creatd Inc.

Creatd is a company dedicated to unlocking creativity for creators, brands and consumers. The company accomplish this through its four business pillars: Creatd Labs, Creatd Partners, Creatd Ventures and Creatd Studios. For more information about the company, please visit www.Creatd.com.  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.